Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type: a Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Attention Deficit Disorder With Hyperactivity
- Sponsor
- Karolinska Institutet
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Brown ADD Scales
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The newly developed CBT for ADHD inattentive-type (ADHD-I) protocol is tested for feasibility and acceptability in a pilot study with a single group design. The study also evaluates measurements and recruiting possibilities, and effects of the intervention. Research hypotheses include: 1. There is a basis for recruiting ADHD-I patients for participation in an RCT at psychiatric outpatient units, 2. The measurements in the study are feasible and reasonable in regards to patient characteristics; that is, the patients are responding to the questionnaires as intended, 3. The CBT for ADHD-I intervention is feasible in terms of treatment completion, compliance to home assignments, and credibility and relevance, and is lacking of or involves a tolerable degree of adverse effects, and 4. The CBT for ADHD-I protocol reduces core symptoms of ADHD-I as well as symptoms of stress, depression, and anxiety, and improves quality of life.
Investigators
Benjamin Bohman
Principal Investigator
Karolinska Institutet
Eligibility Criteria
Inclusion Criteria
- •In addition to an ADHD inattentive-type diagnosis, inclusion criteria are:
- •18 years or older,
- •intelligence quotient above 80-85, and
- •if on medication, it needs to be well-established since three months.
Exclusion Criteria
- •autism spectrum disorder,
- •ongoing substance use disorder,
- •difficulties in compliance with medical or other treatment,
- •social and/or psychiatric problems to such an extent that it prevents focusing on treatment, or
- •ongoing cognitive-behavioral therapy.
Outcomes
Primary Outcomes
Brown ADD Scales
Time Frame: 14 weeks
Diagnostic measure